In Figure 7A, the top six cancer hallmarks were remarkably enriched in the CRBS-high group, including glycolysis, hypoxia, mTORC1 pathway, MYC target, PI3K/Akt/mTOR and unfolded protein response. The gene discussed is MTOR; the disease is cancer.